Commentary on Effects of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study 5-Year Analysis of the EORTC-NCIC Trial (Lancet Oncol. 2009;10:459-466).

In this article the author discusses the study deficiencies in the article by Stupp and colleagues. She points out that the authors neglected to put any reference to Weller and colleagues' article, and that their published article did not receive a peer review. She also poses that the title of the article was criticized since it does not only talk about patients with glioblastoma but also patients with other histologies.